“Rituximab Exposure in Utero Leading to Late-Onset Neutropenia in Infant: A Case Report and Call for Management Guidelines”

https://pubmed.ncbi.nlm.nih.gov/38116592

This abstract reports a rare case of late-onset neutropenia in an infant whose mother received the drug rituximab two weeks before giving birth, highlighting the need for guidelines on managing in utero exposure to this medication.